KPIs & Operating Metrics(New)
Growth Metrics

Chemed (CHE) Capital Expenditures (2016 - 2026)

Chemed filings provide 18 years of Capital Expenditures readings, the most recent being $17.1 million for Q1 2026.

  • For the quarter ending Q1 2026, Capital Expenditures rose 28.89% year-over-year to $17.1 million, compared with a TTM value of $66.6 million through Mar 2026, up 31.56%, and an annual FY2025 reading of $62.8 million, up 26.78% over the prior year.
  • Capital Expenditures hit $17.1 million in Q1 2026 for Chemed, up from $16.3 million in the prior quarter.
  • The five-year high for Capital Expenditures was $18.3 million in Q4 2022, with the low at $11.1 million in Q2 2024.
  • Median Capital Expenditures over the past 5 years was $13.5 million (2022), compared with a mean of $14.3 million.
  • The sharpest move saw Capital Expenditures plummeted 35.49% in 2023, then soared 42.9% in 2025.
  • Year by year, Capital Expenditures stood at $18.3 million in 2022, then crashed by 35.49% to $11.8 million in 2023, then grew by 8.34% to $12.8 million in 2024, then increased by 28.11% to $16.3 million in 2025, then grew by 4.7% to $17.1 million in 2026.
  • According to Business Quant data, Capital Expenditures over the past three periods came in at $17.1 million, $16.3 million, and $17.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.